Proshares Trust (ZBIO) Research & Development (2023 - 2025)
Historic Research & Development for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $34.4 million.
- Zenas BioPharma's Research & Development rose 260.07% to $34.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.5 million, marking a year-over-year increase of 4628.71%. This contributed to the annual value of $139.1 million for FY2024, which is 13177.09% up from last year.
- As of Q3 2025, Zenas BioPharma's Research & Development stood at $34.4 million, which was up 260.07% from $43.0 million recorded in Q2 2025.
- In the past 5 years, Zenas BioPharma's Research & Development registered a high of $49.2 million during Q4 2024, and its lowest value of $9.4 million during Q3 2023.
- Over the past 3 years, Zenas BioPharma's median Research & Development value was $33.8 million (recorded in 2024), while the average stood at $31.3 million.
- In the last 5 years, Zenas BioPharma's Research & Development skyrocketed by 25853.29% in 2024 and then surged by 260.07% in 2025.
- Over the past 3 years, Zenas BioPharma's Research & Development (Quarter) stood at $20.4 million in 2023, then skyrocketed by 140.75% to $49.2 million in 2024, then crashed by 30.02% to $34.4 million in 2025.
- Its last three reported values are $34.4 million in Q3 2025, $43.0 million for Q2 2025, and $34.9 million during Q1 2025.